Advertisement

Actos May Help Slow Heart Disease

According to a new study, the Type 2 diabetes drug pioglitazone (brand name Actos) appears to slow the progression of coronary atherosclerosis, or narrowing of the heart’s arteries due to plaque buildup, better than an older diabetes drug, glimepiride (Amaryl, also available generically). People who have diabetes are at increased risk of developing heart disease, and coronary atherosclerosis can lead to angina or heart attack. Read More “Actos May Help Slow Heart Disease”

Weight, Prejudice, and Type 2 Diabetes

Do you think overweight people bring Type 2 diabetes on themselves? It would be natural to think that, because doctors and other authorities have been blaming weight for years. Health "experts” call Type 2 a "lifestyle disease," implying that people choose it. Heavy people are called "obese," which comes from the Latin for "over/eating," as if that were the whole cause of overweight. Read More “Weight, Prejudice, and Type 2 Diabetes”

ADVANCE Study Contradicts ACCORD Findings

The surprising and much-publicized early findings from the ACCORD study, which showed a slightly increased risk of death among certain people with Type 2 diabetes who used intensive drug therapy to lower blood glucose levels, have prompted researchers conducting a similar ongoing study to release early results. The ADVANCE study, which is the largest study ever of aggressive blood glucose control in people with Type 2 diabetes, has found no increase in risk of death associated with intensive treatment. Read More “ADVANCE Study Contradicts ACCORD Findings”

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites